Hitoshi Okada

7.1k total citations · 1 hit paper
107 papers, 5.1k citations indexed

About

Hitoshi Okada is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Hitoshi Okada has authored 107 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Immunology. Recurrent topics in Hitoshi Okada's work include Epigenetics and DNA Methylation (10 papers), Cell death mechanisms and regulation (7 papers) and Histone Deacetylase Inhibitors Research (5 papers). Hitoshi Okada is often cited by papers focused on Epigenetics and DNA Methylation (10 papers), Cell death mechanisms and regulation (7 papers) and Histone Deacetylase Inhibitors Research (5 papers). Hitoshi Okada collaborates with scholars based in Japan, Canada and United States. Hitoshi Okada's co-authors include Tak W. Mak, Andrew Wakeham, Gordon S. Duncan, Andrew Elia, Tetsuo Noda, Tak W. Mak, Shigeru Katamine, Woong‐Kyung Suh, Sumitaka Hasegawa and Scott W. Lowe and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Hitoshi Okada

104 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathways of apoptotic and non-apoptotic death in tumour cells

2004 803 citations Hitoshi Okada, Tak W. Mak profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hitoshi Okada Japan	34	3.4k	1.0k	895	544	537	107	5.1k
Rosemary O’Connor Ireland	39	3.1k 0.9×	841 0.8×	725 0.8×	418 0.8×	646 1.2×	99	5.3k
Lawrence C. Fritz United States	25	3.6k 1.1×	811 0.8×	1.5k 1.6×	503 0.9×	319 0.6×	33	6.0k
Yue‐Ming Li United States	48	4.6k 1.4×	1.4k 1.4×	599 0.7×	961 1.8×	805 1.5×	150	8.6k
Wendy J. Fantl United States	38	4.7k 1.4×	1.1k 1.1×	1.8k 2.0×	666 1.2×	513 1.0×	68	7.2k
Elena Feinstein United States	40	4.2k 1.2×	1.2k 1.2×	806 0.9×	656 1.2×	1.1k 2.1×	63	6.7k
Christopher M. Tan United States	18	3.8k 1.1×	591 0.6×	843 0.9×	353 0.6×	803 1.5×	40	6.1k
Futoshi Shibasaki Japan	39	4.4k 1.3×	660 0.7×	719 0.8×	836 1.5×	690 1.3×	96	6.1k
David K. Han United States	33	3.6k 1.1×	502 0.5×	1.4k 1.6×	707 1.3×	611 1.1×	61	5.6k
Margaret Favata United States	19	2.6k 0.8×	819 0.8×	1.2k 1.4×	346 0.6×	471 0.9×	28	4.7k
Hansruedi Loetscher Switzerland	34	2.4k 0.7×	700 0.7×	2.2k 2.5×	288 0.5×	639 1.2×	47	5.6k

Countries citing papers authored by Hitoshi Okada

Since Specialization

Citations

This map shows the geographic impact of Hitoshi Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Okada more than expected).

Fields of papers citing papers by Hitoshi Okada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Okada. The network helps show where Hitoshi Okada may publish in the future.

Co-authorship network of co-authors of Hitoshi Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Okada. A scholar is included among the top collaborators of Hitoshi Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Okada. Hitoshi Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patel, Manish, E.P. Hamilton, Sarina A. Piha‐Paul, et al.. (2024). 610O Preliminary results from a phase I, first-in-human study of DS-9606a, a claudin 6 (CLDN6)-directed antibody-drug conjugate (ADC), in patients (pts) with tumor types known to express CLDN6. Annals of Oncology. 35. S488–S489. 7 indexed citations

Takasaki, Teruaki, Takeshi Ueda, Hitoshi Okada, et al.. (2024). ACA-28, an ERK MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic Cancer Cells. Oxidative Medicine and Cellular Longevity. 2024. 1–12. 1 indexed citations

Ueda, Takeshi, Akiyoshi Komuro, H. Amano, et al.. (2023). MYC/Glutamine Dependency Is a Therapeutic Vulnerability in Pancreatic Cancer with Deoxycytidine Kinase Inactivation-Induced Gemcitabine Resistance. Molecular Cancer Research. 21(5). 444–457. 7 indexed citations

Yi, Sun-Ju, Hye‐Jung Kim, Kyubin Lee, et al.. (2021). The KDM4B–CCAR1–MED1 axis is a critical regulator of osteoclast differentiation and bone homeostasis. Bone Research. 9(1). 27–27. 27 indexed citations

Glaser, Simone-Franziska, Andreas W. Heumüller, Lukas Tombor, et al.. (2020). The histone demethylase JMJD2B regulates endothelial-to-mesenchymal transition. Proceedings of the National Academy of Sciences. 117(8). 4180–4187. 41 indexed citations

Hitachi, Keisuke, Hidehito Inagaki, Hiroki Kurahashi, et al.. (2019). Deficiency of Vgll2 Gene Alters the Gene Expression Profiling of Skeletal Muscle Subjected to Mechanical Overload. Frontiers in Sports and Active Living. 1. 41–41. 2 indexed citations

Okada, Hitoshi, et al.. (2017). A review of blockchain technology applications for academic institutions. IEICE Technical Report; IEICE Tech. Rep.. 117(340). 11–14. 2 indexed citations

Legaspi, Roberto, et al.. (2016). Solving the Difficult Problem of Topic Extraction in Thai Tweets. Journal of Telecommunication Electronic and Computer Engineering (JTEC). 8(6). 141–145. 1 indexed citations

Sasaki, Toru, Eugene Gan, Andrew Wakeham, et al.. (2007). HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53. Genes & Development. 21(7). 848–861. 106 indexed citations

10.

Yokomizo, Tomomasa, Satoru Takahashi, Naomi Mochizuki, et al.. (2006). Characterization of GATA‐1+ hemangioblastic cells in the mouse embryo. The EMBO Journal. 26(1). 184–196. 46 indexed citations

11.

Tsuchihara, Katsuya, Chris Bakal, Hitoshi Okada, et al.. (2005). Ckap2 Regulates Aneuploidy, Cell Cycling, and Cell Death in a p53-Dependent Manner. Cancer Research. 65(15). 6685–6691. 42 indexed citations

12.

Hao, Zhenyue, Gordon S. Duncan, Chia‐Che Chang, et al.. (2005). Specific Ablation of the Apoptotic Functions of Cytochrome c Reveals a Differential Requirement for Cytochrome c and Apaf-1 in Apoptosis. Cell. 121(4). 579–591. 213 indexed citations

13.

Martins, L. Miguel, Alastair Morrison, Kristina Klupsch, et al.. (2004). Neuroprotective Role of the Reaper-Related Serine Protease HtrA2/Omi Revealed by Targeted Deletion in Mice. Molecular and Cellular Biology. 24(22). 9848–9862. 315 indexed citations

14.

Suh, Woong‐Kyung, Agostino Tafuri, Arda Shahinian, et al.. (2004). The Inducible Costimulator Plays the Major Costimulatory Role in Humoral Immune Responses in the Absence of CD28. The Journal of Immunology. 172(10). 5917–5923. 47 indexed citations

15.

Beppu, Hideyuki, Hitoshi Okada, Masahiro Kawabata, et al.. (2002). Compound disruption of smad2 accelerates malignant progression of intestinal tumors in apc knockout mice.. PubMed. 62(20). 5955–61. 62 indexed citations

16.

Hayashi, Keitaro, Waka Natsume, Toshio Watanabe, et al.. (2000). Diminution of the AML1 Transcription Factor Function Causes Differential Effects on the Fates of CD4 and CD8 Single-Positive T Cells. The Journal of Immunology. 165(12). 6816–6824. 56 indexed citations

17.

Bell, Stephen P., et al.. (1996). A novel inhibitor of plasminogen activator inhibitor-1, T-686, modulates development of atherosclerosis in vivo in rabbits. Journal of the American College of Cardiology. 27(2). 64–64. 1 indexed citations

18.

Okada, Hitoshi, et al.. (1986). Acoustic Properties of Infant Cries and Maternal Perception. 44. 51–58. 6 indexed citations

19.

Okada, Hitoshi, et al.. (1985). MATERNAL PERCEPTION OF INFANT CRIES. The Japanese Journal of Educational Psychology. 33(2). 146–151. 4 indexed citations

20.

Okada, Hitoshi. (1985). Initial and Terminal Pitch of Uni-Directionaly Frequency Modulated Tones. 43. 49–55. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact